Difference between revisions of "Drug index"
Jump to navigation
Jump to search
m |
(→P) |
||
| Line 117: | Line 117: | ||
==P== | ==P== | ||
*[[Paclitaxel (Taxol)]] | *[[Paclitaxel (Taxol)]] | ||
| − | *[[Paclitaxel | + | *[[Paclitaxel, albumin-bound (Abraxane)]] |
*[[Panitumumab (Vectibix)]] | *[[Panitumumab (Vectibix)]] | ||
*[[Peg-asparginase (Oncospar)]] | *[[Peg-asparginase (Oncospar)]] | ||
Revision as of 16:14, 15 November 2011
- List of chemotherapy regimens
- Vesicant & irritant chemotherapy
- Antiemetic support
- (List also includes non-chemotherapy medications used in hematology/oncology, such as aromatase inhibitors.)
A
- Aldesleukin (Proleukin)
- Alemtuzumab (Campath)
- Altretamine (Hexalen)
- Aminoglutethimide (Cytadren)
- Anagrelide (Agrylin)
- Anastrozole (Arimidex)
- Arsenic trioxide (Trisenox)
- Asparaginase (Elspar)
- Azacitadine (Vidaza)
B
- Bacillus Calmette-Guerin (BCG)
- Bendamustine (Treanda)
- Bevacizumab (Avastin)
- Bexarotene (Targretin)
- Bicalutamide (Casodex)
- Bleomycin (Blenoxane)
- Bortezomib (Velcade)
- Busulfan (Busulfex)
C
- Cabazitaxel (Jevtana)
- Capecitabine (Xeloda)
- Carboplatin (Paraplatin)
- Carmustine (Bicnu)
- Cetuximab (Erbitux)
- Chlorambucil (Leukeran)
- Cisplatin (Platinol)
- Cladribine (Leustatin)
- Clofarabine (Clolar)
- Cyclophosphamide (Cytoxan)
- Cytarabine (Cytosar)
- Cytarabine Liposomal (DepoCyt)
D
- Dacarbazine (DTIC)
- Dactinomycin (Cosmegen)
- Dasatinib (Sprycel)
- Daunorubicin (Cerubidine)
- Daunorubicin Liposomal (Daunoxome)
- Decitabine (Dacogen)
- Degarelix (Firmagon)
- Denileukin Difitox (Ontak)
- Docetaxel (Taxotere)
- Doxorubicin (Adriamycin)
- Doxorubicin Liposomal (Doxil)
- Dutasteride (Avodart)
E
- Epirubicin (Ellence)
- Eribulin (Halaven)
- Erlotinib (Tarceva)
- Estramustine (Emcyt)
- Etoposide (Vepesid)
- Everolimus (Afinitor)
- Estramustine (Emcyt)
- Exemestane (Aromasin)
F
- [[Finasteride (Proscar)
- Floxuridine (FDUR)
- Fludarabine (Fludara)
- Flutamide (Eulexin)
- Fulvestrant (Faslodex)
G
H
I
- Ibritumomab (Zevalin)
- Idarubicin (Idamycin)
- Ifosfamide (Ifex)
- Imatinib (Gleevec)
- Ipilimumab (Yervoy)
- Interferon alfa-2a (Roferon-A)
- Interferon alfa-2b (Intron-A)
- Irinotecan (Camptosar)
- Ixabepilone (Ixempra)
L
M
- Mechlorethamine (Mustargen)
- Melphalan (Alkeran)
- Mercaptopurine (Purinethol)
- Methotrexate (MTX)
- Mitomycin (Mutamycin)
- Mitotane (Lysodren)
- Mitoxantrone (Novantrone)
N
O
P
- Paclitaxel (Taxol)
- Paclitaxel, albumin-bound (Abraxane)
- Panitumumab (Vectibix)
- Peg-asparginase (Oncospar)
- Pemetrexed (Alimta)
- Pentostatin (Nipent)
- Porfimer (Photofrin)
- Pralatrexate (Folotyn)
- Procarbazine (Matulane)
R
S
T
- Tamoxifen (Nolvadex)
- Temozolmide (Temodar)
- Temsirolimus (Torisel)
- Teniposide (Vumon)
- Thalidomide (Thalomid)
- Thioguanine (Tabloid)
- Thiotepa (Thioplex)
- Topotecan (Hycamtin)
- Toremifene (Fareston)
- Tositumomab & I-131 (Bexxar)
- Trastuzumab (Herceptin)
- Tretinoin (Vesanoid)
- Triptorelin (Trelstar LA)
V
Reference
Chemotherapy Order of Administration (ONS recommendations-PDF)